E Fund Management’s Mirum Pharmaceuticals MIRM Stock Holding History

E Fund Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$513K	Sell	4,386 -1,961	-31%	-$197K	0.01%	259
2026 Q1	$586K	Buy	+6,347	New	+$597K	0.02%	255
2025 Q2	$211K	Sell	4,143 -704	-15%	-$31.3K	0.01%	352
2025 Q1	$218K	Buy	+4,847	New	+$228K	0.01%	351
2024 Q4	–	Sell	-5,491	Closed	-$214K	–	406
2024 Q3	$214K	Buy	+5,491	New	+$219K	0.01%	316
2024 Q2	–	Sell	-12,583	Closed	-$316K	–	352
2024 Q1	$316K	Buy	12,583 +5,582	+80%	+$153K	0.02%	271
2023 Q4	$207K	Sell	7,001 -49	-0.7%	-$1.48K	0.01%	277
2023 Q3	$223K	Buy	+7,050	New	+$193K	0.02%	240

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

E Fund Management's MIRM Position: Q2 2026 in Review

E Fund Management reduced its Mirum Pharmaceuticals (MIRM) stake by 31% in Q2 2026, selling an estimated $197K and leaving 4,386 shares worth $513K. The position accounts for 0.01% of the portfolio, ranked #259.

E Fund Management first reported a position in MIRM in Q3 2023 and has held it in 8 quarters since. The position peaked at $586K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

E Fund Management held 4,386 shares of Mirum Pharmaceuticals worth $513K as of Q2 2026.
E Fund Management sold 1,961 Mirum Pharmaceuticals shares in Q2 2026, an estimated $197K.
Mirum Pharmaceuticals made up 0.01% of E Fund Management's portfolio in Q2 2026, its #259 holding.
E Fund Management first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
E Fund Management's Mirum Pharmaceuticals position peaked at $586K in Q1 2026.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.